Literature DB >> 11167820

Leukaemia - a brief historical review from ancient times to 1950.

G Piller1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11167820     DOI： 10.1046/j.1365-2141.2001.02411.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

Review 1.  Observations of unprecedented remissions following novel treatment for acute leukemia in children in 1948.

Authors:  Peter D Spain; Nina Kadan-Lottick
Journal:  J R Soc Med       Date:  2012-04       Impact factor: 5.344

Review 2.  Supportive care in patients with acute leukaemia: historical perspectives.

Authors:  Giovanna Cannas; Xavier Thomas
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

Review 3.  Using Pharmacology to Squeeze the Life Out of Childhood Leukemia, and Potential Strategies to Achieve Breakthroughs in Medulloblastoma Treatment.

Authors:  Juwina Wijaya; Tomoka Gose; John D Schuetz
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

Review 4.  How is the Ph-like signature being incorporated into ALL therapy?

Authors:  Luke Maese; Sarah K Tasian; Elizabeth A Raetz
Journal:  Best Pract Res Clin Haematol       Date:  2017-06-15       Impact factor: 3.020

5.  Malignant but not maleficent: acute leukaemia as a possible explanation of disease and death in vampire victims.

Authors:  Stinne Tranekær; Claus Werenberg Marcher; Henrik Frederiksen; Dennis Lund Hansen
Journal:  Ir J Med Sci       Date:  2019-11-12       Impact factor: 1.568

Review 6.  Overview of Myeloproliferative Neoplasms: History, Pathogenesis, Diagnostic Criteria, and Complications.

Authors:  Douglas Tremblay; Abdulraheem Yacoub; Ronald Hoffman
Journal:  Hematol Oncol Clin North Am       Date:  2021-01-26       Impact factor: 3.722

Review 7.  The granulocyte nucleus and lamin B receptor: avoiding the ovoid.

Authors:  Katrin Hoffmann; Karl Sperling; Ada L Olins; Donald E Olins
Journal:  Chromosoma       Date:  2007-01-24       Impact factor: 2.919

8.  Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells.

Authors:  Erin H Breese; Corina Buechele; Catherine Dawson; Michael L Cleary; Matthew H Porteus
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.